Cancer loyalty card study-2 (CLOCS-2): protocol for an observational case-control study focusing on the patient interval in cancer diagnosis.
| Title: | Cancer loyalty card study-2 (CLOCS-2): protocol for an observational case-control study focusing on the patient interval in cancer diagnosis. |
|---|---|
| Authors: | Toopchiani S; Surgery and Cancer, Imperial College London, London, UK.; Codling S; Surgery and Cancer, Imperial College London, London, UK.; Pondeca Y; Surgery and Cancer, Imperial College London, London, UK.; Kaur S; Surgery and Cancer, Imperial College London, London, UK.; Horeau K; Surgery and Cancer, Imperial College London, London, UK.; Department of Computing, Imperial College London, London, UK.; Brewer H; Surgery and Cancer, Imperial College London, London, UK.; Cross A; Epidemiology and Biostatistics, Imperial College London, London, UK.; Delaney B; Surgery and Cancer, Imperial College London, London, UK.; Faisal AA; Department of Surgery and Cancer, Imperial College London, London, UK.; Peters C; Surgery and Cancer, Imperial College London, London, UK.; Goulding J; Nottingham University Business School, Nottingham, UK.; Hirst Y; Health Technology Assessment Unit (HTA), University of Central Lancashire, Preston, UK.; Sundar S; Cancer Sciences, University of Birmingham, Birmingham, UK.; Flanagan JM; Surgery and Cancer, Imperial College London, London, UK j.flanagan@imperial.ac.uk. |
| Source: | BMJ open [BMJ Open] 2026 May 13; Vol. 16 (5), pp. e117937. Date of Electronic Publication: 2026 May 13. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [London] : BMJ Publishing Group Ltd, 2011- |
| MeSH Terms: | Neoplasms*/diagnosis ; Early Detection of Cancer*; Humans ; Case-Control Studies ; Female ; Retrospective Studies ; United Kingdom ; Research Design ; Observational Studies as Topic |
| Abstract: | Introduction: Some cancers are diagnosed late, making them harder to treat. People with an undiagnosed cancer may use over-the-counter medications to manage non-specific cancer-related symptoms that often mimic other more common, easily treatable conditions. Results from the original Cancer Loyalty Card Study (CLOCS) suggest there may be an increase in purchases of pain and indigestion medication 8-9 months before an ovarian cancer diagnosis. We aim to validate the CLOCS findings by exploring whether a significant change in medication purchases could be an indication for early signs of the following cancer types: oesophageal, stomach (gastric), colorectal (bowel), pancreatic, liver, bladder, endometrial, uterine sarcoma, ovarian and vulval, using data collected through store loyalty cards.; Methods and Analysis: Using a retrospective case-control design, we aim to recruit 1450 participants with one of the cancers of interest (cases) and 1450 participants without cancer (controls) in the UK who (or whose household members) hold a loyalty card with at least one participating high street retailer. We will use pre-existing loyalty card data to compare past purchase patterns of cases with those of controls. To assess cancer risk in participants and their purchasing patterns, we will collect information on demographic characteristics, health risk factors, lifestyle habits and behaviours, family history of cancer and any symptoms experienced prior to diagnosis (cases) and in the last year prior to study recruitment (controls). In addition, cases will be asked about their cancer diagnosis.; Ethics and Dissemination: CLOCS-2 was reviewed and approved by the East Midlands-Leicester South Research Ethics Committee (23/EM/0224). Study outcomes will be disseminated through peer-reviewed publications, conferences, presentations to the research communities as well as patients and the public, the study website and other social media outlets.; Trial Registration Number: NCT06447064, CPMS58679; pre-results.; (© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group.) |
| Competing Interests: | Competing interests: None declared. |
| Contributed Indexing: | Keywords: Clinical Protocols; Early Detection of Cancer; Epidemiology; Health informatics |
| Molecular Sequence: | ClinicalTrials.gov NCT06447064 |
| Entry Date(s): | Date Created: 20260513 Date Completed: 20260513 Latest Revision: 20260520 |
| Update Code: | 20260520 |
| PubMed Central ID: | PMC13182332 |
| DOI: | 10.1136/bmjopen-2026-117937 |
| PMID: | 42128509 |
| Database: | MEDLINE |
Journal Article